TalkGlitz Archive Today’s stories

NewsNews Update

Nnamdi Kanu's Health Deteriorating In DSS Custody - Lawyer

Nnamdi Kanu, the leader of the Indigenous People of Biafra (IPOB), is reportedly bleeding from his nose after allegedly coming into contact with a tuberculosis patient in the custody of the Department of State Services (DSS).

This was revealed by his lawyer, Aloy Ejimakor, through his official Twitter handle on Monday.

Ejimakor stated that one of his associates, Barrister Mandela, met with Kanu at the DSS cell and was directed by the IPOB leader to make it public that he had an episode of profuse nose bleeding on Monday.

The lawyer also alleged that a detainee who was diagnosed with tuberculosis had been transferred to Kanu's cell block, which he described as "ominous."

He wrote: “Today, my associate, Barr Mandela, met with Onyendu, MNK (Kanu) at the DSS.

“He reports that MNK (Kanu) directed me to make it public that he had an episode of profuse nose bleeding yesterday and that the DSS has transferred a detainee diagnosed with tuberculosis to his cell block. This is ominous.

"Except for failed nations, there's no nation that detains a man after his incarceration has been municipally and internationally declared illegal, with compensation and apology awarded to him."

View on X

Nnamdi Kanu was arrested in June 2021 and has been in the custody of the DSS ever since. He was extradited to Nigeria from Kenya, where he had been living in exile since 2017. Kanu is facing charges of treasonable felony, terrorism, and illegal possession of firearms, among others.

More from News

News

Fashola Speaks On Tinubu's Alleged Dual Citizenship

The Minister of Works and Housing, Babatunde Fashola, has expressed doubt over constitutionally provided restrictions on a presidential candidate with dual citizenship from running for elections. Fashola shared his…

News

FG Approves Use Of R21 Malaria Vaccine

The Federal Government has granted provisional approval to the R21/Matrix malaria vaccine. This vaccine was developed by scientists at Oxford University and is said to be 80% effective in preventing clinical malaria in…

All News stories April 2023